JP Morgan Chase’s Legend Biotech LEGN Stock Holding History

JP Morgan Chase’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24,000	Closed	-$522K	–	7734
2025 Q4	$522K	Buy	+24,000	New	+$687K	﹤0.01%	4993
2024 Q4	–	Sell	-1,400	Closed	-$68.2K	–	7586
2024 Q3	$68.2K	Hold	1,400	–	–	﹤0.01%	5870
2024 Q2	$62K	Hold	1,400	–	–	﹤0.01%	5766
2024 Q1	$78.5K	Hold	1,400	–	–	﹤0.01%	5773
2023 Q4	$84.2K	Buy	+1,400	New	+$88.7K	﹤0.01%	5813
2023 Q1	–	Sell	-31,100	Closed	-$1.55M	–	6997
2022 Q4	$1.55M	Sell	31,100 -10,900	-26%	-$528K	﹤0.01%	3750
2022 Q3	$1.71M	Hold	42,000	–	–	﹤0.01%	3599
2022 Q2	$2.31M	Hold	42,000	–	–	﹤0.01%	3419
2022 Q1	$1.53M	Buy	+42,000	New	+$1.66M	﹤0.01%	3959
2021 Q3	–	Sell	-30,000	Closed	-$1.23M	–	6655
2021 Q2	$1.23M	Buy	+30,000	New	+$1.02M	﹤0.01%	4152

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase's LEGN Position: Q1 2026 in Review

JP Morgan Chase reduced its Legend Biotech (LEGN) stake by 70% in Q1 2026, selling an estimated $12.5M and leaving 288,103 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

JP Morgan Chase first reported a position in LEGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $39.7M in Q2 2023. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

JP Morgan Chase held 288,103 shares of Legend Biotech worth $4.99M as of Q1 2026.
JP Morgan Chase sold 657,591 Legend Biotech shares in Q1 2026, an estimated $12.5M.
Legend Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3297 holding.
JP Morgan Chase first reported a position in Legend Biotech in Q2 2020 and has held it in 24 quarters since.
JP Morgan Chase's Legend Biotech position peaked at $39.7M in Q2 2023.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.